Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 11, 2022, Ashish Sanghrajka tendered a letter of resignation from the Board of Directors of Scopus BioPharma Inc. (the "Company"), effective immediately (the "Sanghrajka Letter"). A copy of the Sanghrajka Letter, which states his reasons for resigning, is furnished herewith as Exhibit 99.1. The Company disagrees with the assertions and characterizations set forth in the Sanghrajka Letter.

Pursuant to the requirements of Item 5.02 of Form 8-K, the Company has provided Mr. Sanghrajka with a copy of this Form 8-K in accordance with Item 5.02(a)(3)(i) of Form 8-K.

Item 9.01. Financial Statement and Exhibits.





(d) Exhibits




    99.1     Letter from Ashish Sanghrajka dated May 11, 2022
  104      Cover Page Interactive Data File (formatted in Inline XBRL and
           contained in Exhibit 101)

© Edgar Online, source Glimpses